DAS-6-2-2-6-CRBN

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDAS-6-2-2-6-CRBN
Drug Alias NameDAS-6-2-2-6-CRBN
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionBcr-Abl tyrosine kinase modulatorsProteolysis
TargetsBcr-Abl tyrosine kinase
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesYale University
China Registration ClassN/A

Develop Information

Active CompaniesYale University
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A